Hong Sun-Pyo, Lee Sang Mi, Yoo Ik Dong, Jo In Young, Won Yong Kyun, Kim Min-Su, Choi Hye Jeong, Lee Jeong Won, Jang Su Jin
Department of Nuclear Medicine, Soonchunhyang University Cheonan Hospital, 31 Suncheonhyang 6-gil, Dongnam-gu, Cheonan, 31151, Republic of Korea.
Department of Radiation Oncology, Soonchunhyang University Cheonan Hospital, 31 Suncheonhyang 6-gil, Dongnam-gu, Cheonan, 31151, Republic of Korea.
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2025 Jul-Aug;44(4):500103. doi: 10.1016/j.remnie.2025.500103. Epub 2025 Feb 5.
The maximum [F]FDG uptake of a cancer lesion has been found to relocate from the center to the periphery during progression. This behavior suggests that the normalized distances from the hotspot of radiotracer uptake to the tumor centroid (NHOC) and to the tumor perimeter (NHOP) could serve as novel geometric PET parameters indicative of tumor aggressiveness. This study aimed to explore the prognostic relevance of NHOC and NHOP in [F]FDG PET/CT for predicting the response to concurrent chemoradiotherapy (CCRT) and progression-free survival (PFS) in patients with head and neck squamous cell carcinoma (HNSCC).
We retrospectively reviewed 116 HNSCC patients who received CCRT and were assessed with pre-treatment (PET1) and three months post-treatment PET/CT (PET2). Along with conventional PET parameters, NHOC and NHOP for primary tumors on PET1 and the percent changes in NHOC and NHOP between PET1 and PET2 were measured.
Of all the PET1 parameters assessed, NHOC was the most effective in predicting the CCRT response, achieving an area under the receiver operating characteristic curve of 0.645. In multivariate logistic regression and survival analysis, NHOC identified as an independent predictor for both complete metabolic response (P = .028) and PFS (P = .006). In a subgroup of 46 patients exhibiting residual primary tumors on PET2, both the percent changes in NHOC (P = .048) and NHOP (P = .041) were significantly associated with PFS.
NHOC and the percent changes in NHOC and NHOP following CCRT may serve as effective [F]FDG PET/CT parameters for predicting clinical outcomes in HNSCC patients.
研究发现,癌症病灶的最大[F]FDG摄取在进展过程中会从中心转移至周边。这种现象表明,放射性示踪剂摄取热点到肿瘤质心的归一化距离(NHOC)以及到肿瘤周边的归一化距离(NHOP),可能作为指示肿瘤侵袭性的新型几何PET参数。本研究旨在探讨[F]FDG PET/CT中NHOC和NHOP对预测头颈部鳞状细胞癌(HNSCC)患者同步放化疗(CCRT)反应及无进展生存期(PFS)的预后价值。
我们回顾性分析了116例接受CCRT的HNSCC患者,这些患者在治疗前(PET1)及治疗后3个月接受了PET/CT评估(PET2)。除了传统PET参数外,还测量了PET1上原发肿瘤的NHOC和NHOP,以及PET1与PET2之间NHOC和NHOP的变化百分比。
在所有评估的PET1参数中,NHOC在预测CCRT反应方面最有效,其受试者工作特征曲线下面积为0.645。在多因素逻辑回归和生存分析中,NHOC被确定为完全代谢反应(P = 0.028)和PFS(P = 0.006)的独立预测因子。在PET2上显示有残留原发肿瘤的46例患者亚组中,NHOC(P = 0.048)和NHOP(P = 0.041)的变化百分比均与PFS显著相关。
NHOC以及CCRT后NHOC和NHOP的变化百分比,可能作为预测HNSCC患者临床结局的有效[F]FDG PET/CT参数。